A detailed history of Fore Capital, LLC transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Fore Capital, LLC holds 90,000 shares of BHC stock, worth $565,200. This represents 0.2% of its overall portfolio holdings.

Number of Shares
90,000
Holding current value
$565,200
% of portfolio
0.2%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

BUY
$5.71 - $8.34 $513,900 - $750,600
90,000 New
90,000 $580,000
Q2 2020

Aug 13, 2020

SELL
$13.31 - $20.51 $133,100 - $205,100
-10,000 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$12.98 - $30.25 $129,800 - $302,500
10,000 New
10,000 $155,000

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.27B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Fore Capital, LLC Portfolio

Follow Fore Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fore Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fore Capital, LLC with notifications on news.